Dipyridamole Assessment for Flare Reduction in Systemic Lupus Erythematosus (SLE)

Condition:   Systemic Lupus ErythematosusInterventions:   Drug: extended release dipyridamole 200mg/aspirin 25mg;   Drug: 81mg aspirinSponsors:   Oklahoma Medical Research Foundation;   Oklahoma Rheumatic Disease Research Cores CenterActive, not recruiting - verified October 2014
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials